KNSA vs LCID · P/E 53, rev $677.6M vs rev $687.8M
Kiniksa Pharmaceuticals Ltd (KNSA) versus Lucid Group Inc (LCID) — a side-by-side from cached financials, not a winner call.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Lucid Group Inc (LCID) is a auto manufacturers company listed on NASDAQ. It is led by Silvio Napoli.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Latest reported LCID revenue for 2026-06-30 was $687.8M. Net income was -$2.06B. LCID currently screens at market cap $2.04B.
KNSA currently screens at market cap $3.73B and trailing P/E 53.2. LCID currently screens at market cap $2.04B.
Not investment advice. Open the KNSA and LCID stock pages for the full models.
Not investment advice.